CALR and cancer: The release/exposure of DAMPs (calreticulin, HMGB1, ATP, IFN) by cancer cells dying after PDT stimulates the presentation of tumour antigens by dendritic cells and polarizes T cell response towards the production of IFN-γ, which are essential for anti-tumour immune responses [50,51,52].